✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Boston Bio Systems Ltd.

BOSTON BIO

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹5 Cr.
P/E
0.00

Boston Bio Systems Ltd.

  • Laser Eyecare
  • Transpact Enterprise
  • GKB Ophthalmics

FAQs on Boston Bio Systems Ltd. Shareprice

Laser Eyecare has given lower returns compared to its competitors.
Laser Eyecare has grown at ~-56.09% over the last 1yrs while peers have grown at a median rate of -24.0%

There is insufficient historical data to gauge this.
Latest PE of Laser Eyecare is 0

View FAQ's On Business

Growth Table

  • Boston Bio Systems Ltd.
  • Transpact Enterprise
  • GKB Ophthalmics

Balance Sheet

  • Boston Bio Systems Ltd.
  • Transpact Enterprise
  • GKB Ophthalmics

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Boston Bio Systems Ltd.
  • Transpact Enterprise
  • GKB Ophthalmics

Cash Flow

  • Boston Bio Systems Ltd.
  • Transpact Enterprise
  • GKB Ophthalmics

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Boston Bio Systems Ltd.
  • Transpact Enterprise
  • GKB Ophthalmics

Quarterly Results

  • Boston Bio Systems Ltd.
  • Transpact Enterprise
  • GKB Ophthalmics

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Boston Bio Systems Ltd. Financials

Laser Eyecare balance sheet is weak and might have solvency issues

Yes, The net debt of Laser Eyecare is increasing.
Latest net debt of Laser Eyecare is ₹5.51 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹5.4 Crs.

No, profit is decreasing.
The profit of Laser Eyecare is -₹0.55 Crs for Mar 2025, -₹0.14 Crs for Mar 2024 and ₹0 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Laser Eyecare latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech